Why is MOTS-c particularly sensitive to light and air?

Its two methionine residues oxidise to the sulfoxide in the presence of oxygen, and light and heat accelerate the reaction. Most 16-mers without methionine are less demanding.

Does MOTS-c need a reducing agent in buffer?

No. Reducing agents address disulfide chemistry, and MOTS-c has no cysteine.

Why avoid shaking the vial?

Shaking creates an air-liquid interface where peptides denature. Foam is the visible evidence. Swirl instead.

MOTS-c (Mitochondrial Peptide)

MOTS-c Storage, Stability and Reconstitution

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-232 cited sources

MOTS-c is supplied lyophilised and is most stable in that state, stored cold, dry and protected from light. Its two methionine residues oxidise readily, which is the principal degradation route. In solution stability falls substantially, and repeated freeze-thaw cycles should be avoided by aliquoting.

Key facts

Supplied as: White lyophilised powder
Main degradation route: Methionine oxidation (+16 Da per residue)
Oxidation-prone residues: Met1, Met6
Disulfide risk: None — no cysteine
Lyophilised storage: Cold, dry, dark
In solution: Markedly less stable than lyophilised
Freeze-thaw: Avoid by aliquoting

Why the lyophilised form is stable

Freeze-drying removes water, and water is a participant in peptide-bond hydrolysis. A dry powder held cold has very limited routes to degrade. This is why peptides are shipped and stored lyophilised rather than in solution, and why the powder's condition on arrival matters — material that has been through a warm transit has spent that time in a less protected state.

The specific vulnerability: methionine

MOTS-c has methionine at positions 1 and 6. The thioether sulfur in methionine oxidises to the sulfoxide readily in the presence of dissolved oxygen, and the reaction is accelerated by light and by temperature. Each oxidation adds 16 Da, so oxidised material appears as +16 and +32 satellites on a mass spectrum. This is the single most likely way a MOTS-c sample degrades, and it is why dark, cold, dry storage is not generic advice for this peptide but a specific response to its sequence.

Research material referenced

MOTS-C 10mg — third-party HPLC tested

View — £24.99

What the absence of cysteine simplifies

With no cysteine there is no disulfide chemistry to manage. Peptides containing free thiols can dimerise or scramble intramolecular bonds, and often need reducing agents in buffer. None of that applies here, which makes MOTS-c handling simpler than its length would suggest.

Reconstitution

Bacteriostatic water — sterile water preserved with 0.9% benzyl alcohol — is the usual diluent for research peptides, because it permits repeated entry into the same vial over a limited window. Solvent should be introduced gently against the vial wall rather than directed onto the powder, and the vial swirled rather than shaken. Vigorous agitation generates an air-liquid interface, and peptides denature at that interface; foaming is a visible sign that it has happened.

Once in solution

Solution-phase material is subject to both hydrolysis and oxidation, and stability falls accordingly. Aliquoting into single-use volumes avoids repeated freeze-thaw cycling, which is independently damaging — each cycle concentrates solutes at the ice boundary and exposes the peptide to interfaces it does not tolerate well.

Signs of a problem

Visible particulates, cloudiness or discolouration in a reconstituted solution indicate something has gone wrong and the material should not be relied on for a measurement. A peptide that will not go into solution at a concentration it previously tolerated is also a signal, commonly of aggregation.

Extended research context

The MOTS-c (Mitochondrial Peptide) deep dive

Deep dive: why a peptide encoded in mitochondrial DNA is unusual

The human mitochondrial genome is 16,569 base pairs encoding 37 genes, and was considered fully characterised by the 1980s: thirteen respiratory-chain proteins, twenty-two transfer RNAs, two ribosomal RNAs. MOTS-c is encoded by a short open reading frame nested inside the 12S rRNA gene — sequence already annotated as doing something else, which is exactly why it went unnoticed. Humanin, found in 2001 inside the 16S rRNA gene, established that the genome held more than its annotation suggested; MOTS-c was found in 2015 by looking deliberately. The implication is that the mitochondrion encodes and releases signalling molecules of its own, rather than only executing instructions sent from the nucleus.

Deep dive: AMPK activation without touching AMPK

AMPK is normally activated when AMP and ADP bind its gamma subunit, making it a direct sensor of the AMP-to-ATP ratio. MOTS-c does not raise that ratio and does not bind the kinase. It inhibits the folate cycle, the one-carbon pathway feeding de novo purine biosynthesis, and the intermediate AICAR accumulates as a result. AICAR is an AMP mimetic — phosphorylated to ZMP, it binds the same regulatory site AMP occupies. So the peptide reaches a cytosolic energy sensor through one-carbon metabolism and a diffusible small molecule, which is a materially different architecture from a receptor-ligand interaction, and different again from metformin's inhibition of complex I.

Deep dive: reading a preclinical literature honestly

Roughly 250 indexed papers exist, and the overwhelming majority are cell and rodent studies. Where humans appear, the work is generally observational: measuring circulating concentrations and correlating them with age, fitness or metabolic state. The 2021 Nature Communications paper is the clearest example of the structure — the human arm measured MOTS-c before and after exercise, finding roughly a 12-fold rise in skeletal muscle against 1.6-fold in circulation, while the interventional work was done in mice. Two inferences the secondary literature routinely makes and the primary literature does not support: that a correlation between low concentrations and poor metabolic health establishes direction, and that a molecule which rises during exercise would reproduce exercise if administered.

Research applications

▸Study of mitochondrial-derived peptides and retrograde signalling
▸AMPK pathway research through non-canonical activation
▸One-carbon and folate-cycle metabolism models
▸Exercise physiology and mitochondrial bioenergetics research
▸Ageing biology and mitochondrial genome expression studies

Handling checklist

✓Store lyophilised material cold, dry and protected from light
✓Expect methionine oxidation as the primary degradation route (+16 Da per residue)
✓No reducing agent needed — the sequence contains no cysteine
✓Introduce diluent gently against the vial wall; swirl rather than shake
✓Aliquot to avoid repeated freeze-thaw cycles
✓Check mass spectrometry for +16 and +32 satellites before relying on a batch

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Reading exercise induction as proof that administration mimics exercise

Fix: The papers report that exercise raises MOTS-c. The reverse inference is not supported and is not claimed.

✗ Treating human observational data as interventional evidence

Fix: Human work measures endogenous concentrations; administration studies were conducted in mice.

✗ Assuming MOTS-c has a cell-surface receptor like humanin

Fix: No receptor is established. Its characterised activity is intracellular.

✗ Storing reconstituted material as though it were as stable as the powder

Fix: Solution-phase material is subject to hydrolysis and oxidation; the lyophilised form is far more stable.

✗ Overlooking WADA status in athlete-adjacent research

Fix: MOTS-c is on the prohibited list; this is relevant to any research context involving competitors.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Frequently asked questions

Why is MOTS-c particularly sensitive to light and air?: Its two methionine residues oxidise to the sulfoxide in the presence of oxygen, and light and heat accelerate the reaction. Most 16-mers without methionine are less demanding.
Does MOTS-c need a reducing agent in buffer?: No. Reducing agents address disulfide chemistry, and MOTS-c has no cysteine.
Why avoid shaking the vial?: Shaking creates an air-liquid interface where peptides denature. Foam is the visible evidence. Swirl instead.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

How we write and check this content Report a factual error in this article

More MOTS-c (Mitochondrial Peptide) articles

Popular across the research hub

One flagship guide from every other research category — keep exploring.

← Back to Forum